Cerebrovascular disease encompasses a spectrum of disorders affecting the blood vessels of the brain, including small vessel disease, large vessel atherosclerosis, cerebral amyloid angiopathy, and microinfarcts. These vascular pathologies are increasingly recognized as major contributors to cognitive decline and dementia, both as primary causes (vascular dementia) and as important co-factors in Alzheimer's disease and other neurodegenerative conditions.
The intersection of cerebrovascular disease and neurodegenerative processes creates a vicious cycle: vascular damage reduces cerebral blood flow and compromises the blood-brain barrier, while neurodegenerative proteinopathies further damage cerebral vessels and pericytes. This bidirectional relationship has major implications for diagnosis, treatment, and prevention of dementia.
flowchart TD
A"Risk Factors" --> B"Small Vessel Disease"
A --> C"Large Vessel Pathology"
A --> D"Cerebral Amyloid Angiopathy"
B --> B1 "Lipohyalinosis"
B --> B2 "Fibrinoid Necrosis"
B --> B3 "Microaneurysms"
C --> C1 "Atherosclerosis"
C --> C2 "Arterial Dissection"
C --> C3 "Embolism"
D --> DA"Aβ Deposition"
D --> E"Vascular Damage"
B"1" --> F"White Matter Hyperintensities"
B"2" --> F
B"3" --> G"Lacunar Infarcts"
C"1" --> G
C"2" --> G
C"3" --> G
E --> H"Microbleeds"
F --> I"Chronic Hypoperfusion"
G --> J"Acute Ischemic Events"
H --> K"Blood-Brain Barrier Breakdown"
I --> L"Cognitive Decline"
J --> L
K --> M"Neuronal Dysfunction"
L --> N"Neurodegeneration"
M --> N
style N fill:#ff6b6b
flowchart TD
subgraph G"enes"
G1 [APOE](/proteins/apoe) --> P1
G2 [NOTCH3](/proteins/notch3) --> P2
G3 [HTRA1](/genes/htra1) --> P3
G4 [COL4A1](/genes/col4a1) --> P4
G5 [TREM2](/mechanisms/trem2) --> P5
end
subgraph Proteins
P1 ApoE4 Protein --> Pa1
P2 [Notch3](/proteins/notch3) --> Pa2
P3 HTRA1 Protease --> Pa3
P4 Collagen IV --> Pa4
P5 [TREM2](/mechanisms/trem2) --> Pa5
end
subgraph Pathways
Pa1 Lipid metabolism, BBB repair --> Ca1
Pa2 Vascular development --> Ca2
Pa3 Extracellular matrix --> Ca3
Pa4 Basement membrane --> Ca4
Pa5 Microglial signaling --> Ca5
end
subgraph Cellular_Effects
Ca1 Endothelial dysfunction --> Ef1
Ca2 Smooth muscle changes --> Ef2
Ca3 Matrix degeneration --> Ef3
Ca4 Pericyte loss --> Ef4
Ca5 [Neuroinflammation](/events/aaic-2026/neuroinflammation) --> Ef5
end
subgraph Phenotypes
Ef1 Reduced CBF --> Ph1
Ef2 Arteriolosclerosis --> Ph2
Ef3 White matter lesions --> Ph3
Ef4 BBB breakdown --> Ph4
Ef5 Microinfarcts --> Ph5
end
Ph1 --> VCI
Ph2 --> VCI
Ph3 --> VCI
Ph4 --> AD
Ph5 --> AD
VCI [Vascular Cognitive Impairment](/diseases/vascular-cognitive-impairment)
AD Alzheimer's Disease w/ Vascular Contributions
style VCI fill:#fff3e0
style AD fill:#fff3e0
| Gene |
Protein |
Function |
Disease Association |
| APOE |
Apolipoprotein E |
Lipid transport, BBB repair |
CAA, AD |
| NOTCH3 |
Notch3 |
Vascular smooth muscle |
CADASIL |
| HTRA1 |
HTRA1 serine protease |
Extracellular matrix |
CARASAL |
| COL4A1 |
Collagen IV α1 |
Basement membrane |
Small vessel disease |
| TREM2 |
TREM2 |
Microglial signaling |
AD, cerebrovascular |
Small vessel disease (SVD) is the most common form of cerebrovascular pathology in aging and dementia. It affects the small arterioles, capillaries, and venules of the brain, leading to:
- White matter hyperintensities: Lesions in the deep white matter visible on MRI
- Lacunar infarcts: Small subcortical infarcts
- Microbleeds: Small hemorrhages detectable on MRI
- Perivascular spaces: Enlarged perivascular spaces
The pathogenesis of SVD involves:
- Lipohyalinosis: Fibrinoid necrosis of vessel walls
- Fibrinoid necrosis: Proteinaceous deposition in vessel walls
- Microaneurysm formation: Weakened vessel wall outpouching
- Pericyte loss: Breakdown of capillary integrity
Atherosclerosis of intracranial and extracranial arteries can lead to:
- Large infarcts: Territorial strokes
- Watershed infarcts: Border zone hypoperfusion
- Intracranial stenosis: Reduced blood flow
- Embolic events: Cholesterol or thrombotic emboli
Cerebral amyloid angiopathy (CAA) involves Aβ deposition in cerebral vessel walls, leading to:
- Vessel wall thickening: Loss of smooth muscle cells
- Microaneurysms: Weakened vessel walls
- Hemorrhages: Lobar hemorrhages, particularly in the occipital lobe
- Cortical microinfarcts: Small ischemic lesions
CAA is present in approximately 80% of Alzheimer's disease brains and represents a major vascular contributor to cognitive decline.
The relationship between vascular pathology and neurodegeneration is bidirectional and creates a vicious cycle:
- Vascular damage reduces clearance of toxic proteins (Aβ, tau, α-synuclein)
- Neurodegenerative proteins damage cerebral vessels directly
- Reduced blood flow impairs nutrient delivery to neurons
- BBB breakdown allows peripheral toxins into the brain
- Pericyte loss compromises neurovascular coupling
¶ Amyloid and Vascular Interaction
The intersection of Aβ pathology and cerebrovascular disease is particularly important:
- Aβ is produced by neurons and cleared via perivascular pathways
- Cerebral vessels express Aβ receptors and transporters
- Aβ deposition in vessels (CAA) impairs vascular function
- Vascular dysfunction reduces Aβ clearance, creating a feed-forward loop
¶ Tau and Vascular Interaction
Tau pathology also interacts with cerebrovascular health:
- Tau oligomers may directly damage endothelial cells
- Neurofibrillary tangles correlate with white matter integrity
- Blood-brain barrier breakdown in tauopathies
- Pericyte involvement in tau propagation
Cerebrovascular disease contributes to multiple cognitive domains:
- Executive dysfunction: Planning, organization, inhibition deficits
- Processing speed: Slowed cognitive processing
- Memory retrieval: Remembering past events
- Attention: Sustained and divided attention deficits
- Apathy: Loss of initiative and interest
- Depression: Mood disturbances
- Anxiety: Worry and fear
- Psychosis: Less common than in pure AD
- Gait disturbance: Small vessel gait (marche à petits pas)
- Urinary incontinence: Early incontinence suggests vascular etiology
- Focal deficits: Stroke-related neurological deficits
- Parkinsonism: Vascular parkinsonism
MRI is the gold standard for cerebrovascular disease assessment:
- White matter hyperintensities: Fazekas scale for severity
- Lacunar infarcts: Small, subcortical lesions
- Microbleeds: Gradient echo or SWI sequences
- Perivascular spaces: T2 hyperintensities
- Neurofilament light chain (NFL): Axonal damage marker
- Tau: Neuronal injury indicator
- Aβ42/40 ratio: Amyloid status
- Vascular endothelial markers: VCAM-1, ICAM-1
- Aβ42: Reduced in CAA
- Tau: Elevated in neurodegeneration
- Neurofilament light chain: Marker of axonal damage
- Albumin ratio: BBB integrity indicator
- Blood pressure control: Target BP <130/80 mmHg
- Diabetes management: HbA1c <7%
- Lipid lowering: Statin therapy
- Antiplatelet therapy: Aspirin or clopidogrel
- Atrial fibrillation: Anticoagulation when indicated
- Physical exercise: Aerobic activity improves cerebrovascular function
- Dietary approaches: Mediterranean or DASH diet
- Cognitive training: Maintaining cognitive reserve
- Social engagement: Reducing isolation
- Antihypertensives: ACE inhibitors, ARBs, calcium channel blockers
- Statins: Lipid-lowering and pleiotropic effects
- Antiplatelets: Secondary stroke prevention
- N-methyl-D-aspartate (NMDA) antagonists: Modest cognitive benefits